LISA KAUTZMAN: Open Payments
NPI 1861462194 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 17 payments from 9 companies in 2025. Trend: 2023 $194 · 2024 $440 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $184 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Janssen Scientific Affairs, LLC | 2 | $57 |
| Alkermes, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: Auvelity, COBENFY, INVEGA SUSTENNA, ARISTADA, CAPLYTA, INGREZZA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across SD — which companies pay providers there.
